Skip to main content

You must have JavaScript enabled in order to access this part of the site. Please enable JavaScript and then reload this page in order to continue.

Update to Physician Chapter in the CSHCN Services Program Provider Manual

Last updated on

On January 1, 2025, the Texas Medicaid & Healthcare Partnership (TMHP) will update the Children with Special Health Care Needs (CSHCN) Services Program Provider Manual, Chapter 31: Physician, subsection 31.2.26.5, “Injection Procedure Codes.”

The following updates will be made:

  • Diagnosis code G360 will be added as a payable diagnosis for ravulizumab-cwvz (Ultomiris) (procedure code J1303).
  • Diagnosis code C9200 will be added as a payable diagnosis for azacitidine (Vidaza) (procedure code J9025).

For more information, call the TMHP-CSHCN Services Program Contact Center at 800-568-2413.